Increased Access to Medications for Opioid Use Disorder during the COVID-19 Epidemic and Beyond
View/download the Presentation Slides:
https://www.networkforphl.org/wp-cont...
July 23 | 2:00 – 3:30 p.m. ET
In response to the concurrent epidemics of COVID-19 and opioid-related harm, federal and state agencies have taken steps to temporarily remove some legal and regulatory barriers to treatment for opioid use disorder (OUD). These changes have the potential to improve access to lifesaving medications for OUD (MOUD), particularly among those most at risk. However, they are set to expire with the COVID-19 public health emergency declaration. This webinar describes these legal and regulatory modifications, how they are being used to increase access to OUD treatment, and opportunities to permanently increase access to MOUD.
This webinar provides you with:
An overview of federal and state laws that regulate access to medications for opioid use disorder (MOUD)
A description of recent regulatory changes that have removed some barriers to MOUD during the COVID-19 epidemic
Specific examples of how that regulatory authority is being used to increase access to MOUD, and the problems that remain
Legislative and regulatory pathways for permanently removing barriers to MOUD
Moderator:
Amy Lieberman, Senior Attorney, Network for Public Health Law Southeastern Region Office
Presenters:
Corey S. Davis, JD, MSPH, Director, Harm Reduction Legal Project, Network for Public Health Law
Elizabeth A. Samuels, MD, MPH, MHS, Assistant Professor, Department of Emergency Medicine, Alpert Medical School of Brown University, Consulting Assistant Medical Director, Rhode Island Dept. of Health Drug Overdose Prevention Program
Zoe Weinstein, MD, MS, Director, Boston Medical Center’s Addiction Consult Service; Assistant Professor, Boston University School of Medicine
Louise Vincent, MPH, Executive Director of NC Survivors Union &Urban Survivors Union
